Bulletin
Investor Alert

New York Markets Close in:

Medexus Pharmaceuticals Inc.

TSE: CA:MDP

GO

Quotes are delayed by 15 min

Feb 1, 2023, 11:00 a.m.

MDP
/zigman2/quotes/208555543/delayed

$

1.86

Change

-0.04 -2.11%

Volume

Volume 3,756

Quotes are delayed by 15 min

/zigman2/quotes/208555543/delayed

Previous close

$ 1.90

$ 1.86

Change

-0.04 -2.11%

Day low

Day high

$1.84

$1.89

Open

52 week low

52 week high

$0.88

$3.45

Open

Marcel Konrad

Currently, Marcel Konrad occupies the position of Chief Financial Officer of Medexus Pharmaceuticals, Inc.

In his past career Mr. Konrad was Chief Financial Officer at CareDx, Inc. and Chief Financial Officer of Santen, Inc.

He received an MBA from the University of San Diego and an undergraduate degree from École des Hautes Études Commerciales de Paris.

Transactions

Date Shares Transaction Value
09/20/2022 6,000   6,660
09/20/2022 5,000   6,450
06/28/2022 6,320   9,732
09/28/2021 400   968
09/28/2021 400   968
09/28/2021 3,100   7,471
09/28/2021 3,100   7,471
09/13/2021 3,500   9,625
09/13/2021 3,500   9,625
07/19/2021 0   0
07/19/2021 0   0

Officers and Executives

Mr. Kenneth d’Entremont
Chief Executive Officer & Director
Mr. Richard Labelle
VP-Allergy, Pediatric & OTC Portfolios
Mr. Marcel Konrad
Chief Financial Officer
Mr. Ian C. Wildgoose Brown
Secretary & General Counsel
Mr. Peter A. van der Velden
Chairman
Ms. Adele M. Gulfo
Independent Director
Mr. Michael Peter Mueller
Independent Director
Mr. Benoit Gravel
Independent Director
Mr. Stephen Nelson
Independent Director
Link to MarketWatch's Slice.